NURIX THERAPEUTICS INC shareholders Q2 2023

NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 126 filers reported holding NURIX THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

NURIX THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Blackstone Inc. 27,119$270,9190.00%
Tower Research Capital LLC (TRC) 2,624$26,2140.00%
UBS Group AG 80,647$805,6630.00%
TWO SIGMA ADVISERS, LP 15,200$151,8480.00%
HSBC HOLDINGS PLC 34,329$346,6320.00%
AMERICAN CENTURY COMPANIES INC 23,063$230,3990.00%
WELLS FARGO & COMPANY/MN 40,013$399,7300.00%
Daiwa Securities Group Inc. 152$20.00%
SIMPLEX TRADING, LLC 5,810$580.00%
CWM, LLC 35$00.00%
MORGAN STANLEY 209,097$2,088,8800.00%
WELLINGTON MANAGEMENT GROUP LLP 140,890$1,407,4910.00%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 20,806$207,8520.00%
Invesco Ltd. 47,732$476,8420.00%
AMALGAMATED BANK 4,504$450.00%
Point72 Asset Management, L.P. 7$670.00%
FRANKLIN RESOURCES INC 22,891$228,6810.00%
Allspring Global Investments Holdings, LLC 5,264$52,5870.00%
US BANCORP \DE\ 827$8,2620.00%
Lindbrook Capital, LLC 174$1,7380.00%
External links

This page lists NURIX THERAPEUTICS INC's shareholders in Q2 2023. To view NURIX THERAPEUTICS INC's shareholder history, click here.